Related references
Note: Only part of the references are listed.A novel DNA aptamer targeting lung cancer stem cells exerts a therapeutic effect by binding and neutralizing Annexin A2
Yi-Ying Wu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2022)
The role of integrins in inflammation and angiogenesis
Olachi J. Mezu-Ndubuisi et al.
PEDIATRIC RESEARCH (2021)
Integrin α3β1 Promotes Invasive and Metastatic Properties of Breast Cancer Cells through Induction of the Brn-2 Transcription Factor
Rakshitha Pandulal Miskin et al.
CANCERS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Advances in Aptamer-Based Biomarker Discovery
Jie Huang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics
Yi Zhong et al.
ANALYTICAL BIOCHEMISTRY (2020)
New perspectives on integrin-dependent adhesions
Magdalene Michael et al.
CURRENT OPINION IN CELL BIOLOGY (2020)
High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer
Qianping Li et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Novel antibody-drug conjugates for triple negative breast cancer
Aiko Nagayama et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Blockade of integrin α3 attenuates human pancreatic cancer via inhibition of EGFR signalling
Jungwhoi Lee et al.
SCIENTIFIC REPORTS (2019)
Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis
Peng Guo et al.
SCIENCE ADVANCES (2019)
ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer
Yan Jiao et al.
ONCOTARGETS AND THERAPY (2019)
Elucidation and Structural Modeling of CD71 as a Molecular Target for Cell-Specific Aptamer Binding
Xiaoqiu Wu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
An ssDNA aptamer selected by Cell-SELEX for the targeted imaging of poorly differentiated gastric cancer tissue
Wanming Li et al.
TALANTA (2019)
Plasticity and intratumoural heterogeneity of cell surface antigen expression in breast cancer
Jan Remsik et al.
BRITISH JOURNAL OF CANCER (2018)
PEGylation of therapeutic oligonucletides: From linear to highly branched PEG architectures
Xueguang Lu et al.
NANO RESEARCH (2018)
High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma
Yu Huang et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Bioapplications of Cell-SELEX-Generated Aptamers in Cancer Diagnostics, Therapeutics, Theranostics and Biomarker Discovery: A Comprehensive Review
Xuehui Pang et al.
CANCERS (2018)
Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice
Jean Albrengues et al.
SCIENCE (2018)
Controlled drug delivery vehicles for cancer treatment and their performance
Sudipta Senapati et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
Aptamers as targeted therapeutics: current potential and challenges
Jiehua Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Characterization of Laminin Binding Integrin Internalization in Prostate Cancer Cells
Lipsa Das et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Quantitative Assessment of the Effects of Trypsin Digestion Methods on Affinity Purification-Mass Spectrometry-based Protein-Protein Interaction Analysis
Yueqing Zhang et al.
JOURNAL OF PROTEOME RESEARCH (2017)
Metastatic cancer cell and tissue-specific fluorescence imaging using a new DNA aptamet developed by Cell-SELEX
Baoyin Yuan et al.
TALANTA (2017)
Ligand-Targeted Drug Delivery
Madduri Srinivasarao et al.
CHEMICAL REVIEWS (2017)
Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer
Keiichi Koshizuka et al.
CANCER SCIENCE (2017)
Antibody-mediated delivery of therapeutics for cancer therapy
Sagun Parakh et al.
EXPERT OPINION ON DRUG DELIVERY (2016)
Cancer biomarker discovery using DNA aptamers
Cheng Jin et al.
ANALYST (2016)
Development of Cell-SELEX Technology and Its Application in Cancer Diagnosis and Therapy
Man Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers
Aaron Prodeus et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
BCMab1, A Monoclonal Antibody against Aberrantly Glycosylated Integrin α3β1, Has Potent Antitumor Activity of Bladder Cancer In Vivo
Chong Li et al.
CLINICAL CANCER RESEARCH (2014)
Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ
Juergen Cox et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
Hongguang Sun et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma
Masaki Nagata et al.
BMC CANCER (2013)
Integrin α3 is overexpressed in glioma stem-like cells and promotes invasion
M. Nakada et al.
BRITISH JOURNAL OF CANCER (2013)
Identification of integrin α3 as a molecular marker of cells undergoing epithelial-mesenchymal transition and of cancer cells with aggressive phenotypes
Takuya Shirakihara et al.
CANCER SCIENCE (2013)
Whole Cell-SELEX Aptamers for Highly Specific Fluorescence Molecular Imaging of Carcinomas In Vivo
Hui Shi et al.
PLOS ONE (2013)
Glycoprotein Profiles of Human Breast Cells Demonstrate a Clear Clustering of Normal/Benign versus Malignant Cell Lines and Basal versus Luminal Cell Lines
Ten-Yang Yen et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Loss of integrin α3 prevents skin tumor formation by promoting epidermal turnover and depletion of slow-cycling cells
Norman Sachs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Metastasis-focused cell-based SELEX generates aptamers inhibiting cell migration and invasion
Elina Zueva et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Cell-Specific Aptamer-Mediated Targeted Drug Delivery
Jiehua Zhou et al.
OLIGONUCLEOTIDES (2011)
Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets
Ruth Cohen et al.
EJNMMI RESEARCH (2011)
In vivo Fluorescence Imaging of Tumors using Molecular Aptamers Generated by Cell-SELEX
Hui Shi et al.
CHEMISTRY-AN ASIAN JOURNAL (2010)
Development of DNA aptamers using Cell-SELEX
Kwame Sefah et al.
NATURE PROTOCOLS (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Linking integrin conformation to function
Janet A. Askari et al.
JOURNAL OF CELL SCIENCE (2009)
Aptamer-facilitated biomarker discovery (AptaBiD)
Maxim V. Berezovski et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
Integrin structures and conformational signaling
Bing-Hao Luo et al.
CURRENT OPINION IN CELL BIOLOGY (2006)
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
EWM Ng et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Integrin-α3 mediates binding of Chordin to the cell surface and promotes its endocytosis
J Larraín et al.
EMBO REPORTS (2003)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
